Neumora Therapeutics NMRA
NASDAQ NMRA
$0.68 -0.01 (-2.05%)
At close: Sep 29, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Other Operating Expenses (2023 - 2025)

Updated

Neumora Therapeutics (NMRA) posted Other Operating Expenses of $5 million for FY2025.

Analysis

Neumora Therapeutics (NMRA) Other Operating Expenses (2023 - 2025) Analysis & Trends

  • Annual Other Operating Expenses shows a three-year compound annual growth rate of -27.3% (FY2022 to FY2025).
  • Business Quant data shows NMRA's Other Operating Expenses at $63.9 million in FY2023 (+391.6%) and $13 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Neumora Therapeutics 129.65 Mn 129.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 5.00 Mn
Dec 31, 2023 63.90 Mn
API Access

Neumora Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=NMRA&period=max&api_key=YOUR_API_KEY